Pyxis Oncology, Inc.
PYXS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $139 | $68 | $60 | $95 |
| - Cash | $9 | $11 | $13 | $19 |
| + Debt | $19 | $19 | $20 | $20 |
| Enterprise Value | $149 | $77 | $67 | $95 |
| Revenue | $0 | $3 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Gross Profit | $0 | $3 | $0 | $0 |
| % Margin | – | 100% | – | – |
| EBITDA | -$21 | -$19 | -$22 | -$19 |
| % Margin | – | -681.4% | – | – |
| Net Income | -$22 | -$18 | -$21 | -$36 |
| % Margin | – | -650.9% | – | – |
| EPS Diluted | -0.35 | -0.3 | -0.35 | -0.58 |
| % Growth | -16.7% | 14.3% | 39.7% | – |
| Operating Cash Flow | -$13 | -$17 | -$23 | -$19 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$13 | -$17 | -$23 | -$19 |